{"id":133993,"date":"2019-04-03T06:28:33","date_gmt":"2019-04-03T04:28:33","guid":{"rendered":"http:\/\/www.myza.co.za\/sa-news-world-first-programme-to-combat-drug-resistant-tb\/"},"modified":"2019-04-03T06:28:33","modified_gmt":"2019-04-03T04:28:33","slug":"sa-news-world-first-programme-to-combat-drug-resistant-tb","status":"publish","type":"post","link":"https:\/\/www.myza.co.za\/press\/sa-news-world-first-programme-to-combat-drug-resistant-tb\/","title":{"rendered":"SA News: World first programme to combat drug resistant TB"},"content":{"rendered":"<p><a target=\"_blank\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.bing.com\/news\/apiclick.aspx?ref=FexRss&#038;aid=&#038;tid=4DC3FAAAAF6146488B053E0955542561&#038;url=https%3a%2f%2fwww.netwerk24.com%2fZA%2fPE-Express%2fworld-first-programme-to-combat-drug-resistant-tb-20190401-2&#038;c=14981537622507704343&#038;mkt=en-us\">World first programme to combat drug resistant TB<\/a>: The emergence of DR TB, particularly Rifampicin resistant TB (RR TB), poses a serious threat to the goal of TB eradication, both in South Africa and worldwide. Until August 2018, the treatment of DR &#8230;<br \/>\n<small><strong>Source:<\/strong> <a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.bing.com\/news\/apiclick.aspx?ref=FexRss&#038;aid=&#038;tid=4DC3FAAAAF6146488B053E0955542561&#038;url=https%3a%2f%2fwww.netwerk24.com%2fZA%2fPE-Express%2fworld-first-programme-to-combat-drug-resistant-tb-20190401-2&#038;c=14981537622507704343&#038;mkt=en-us\">&#8220;South Africa&#8221; &#8211; BingNews<\/a><\/small><br \/>\n<\/p>\n<p><a target=\"_blank\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.bing.com\/news\/apiclick.aspx?ref=FexRss&#038;aid=&#038;tid=4DC3FAAAAF6146488B053E0955542561&#038;url=https%3a%2f%2fwww.iol.co.za%2fbusiness-report%2feconomy%2finvestment-by-pic-into-ayo-remains-viable-20517438&#038;c=13712709635732060021&#038;mkt=en-us\">Investment by PIC into AYO remains viable<\/a>: In addition to being an equity holder in BT, AYO had entered into a BT Alliance Agreement, in terms of which, AYO would be one of BT\u2019s strategic partners in South Africa \u2013 as per AYO\u2019s pre-listing &#8230;<br \/>\n<small><strong>Source:<\/strong> <a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.bing.com\/news\/apiclick.aspx?ref=FexRss&#038;aid=&#038;tid=4DC3FAAAAF6146488B053E0955542561&#038;url=https%3a%2f%2fwww.iol.co.za%2fbusiness-report%2feconomy%2finvestment-by-pic-into-ayo-remains-viable-20517438&#038;c=13712709635732060021&#038;mkt=en-us\">&#8220;South Africa&#8221; &#8211; BingNews<\/a><\/small><br \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>World first programme to combat drug resistant TB: The emergence of DR TB, particularly Rifampicin resistant TB (RR TB), poses a serious threat to the goal of TB eradication, both in South Africa and worldwide. Until August 2018, the treatment of DR &#8230; Source: &#8220;South Africa&#8221; &#8211; BingNews Investment by PIC into AYO remains viable: [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","ngg_post_thumbnail":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[11420,4139,3944,830,4378,25040,2213],"class_list":{"0":"post-133993","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-south-africa","7":"tag-combat","8":"tag-drug","9":"tag-first","10":"tag-news","11":"tag-programme","12":"tag-resistant","13":"tag-world","14":"entry"},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/posts\/133993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/comments?post=133993"}],"version-history":[{"count":0,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/posts\/133993\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/media?parent=133993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/categories?post=133993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/tags?post=133993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}